Given the importance of the retromer in modulating protein trafficking, and its implications in neurodegenerative disease, pharmacological interventions have been designed to help stabilize retromer components and maintain protein trafficking, demonstrating the potential for modulating the processing and clearance of APP and pTau, two AD-related proteins [55,56]. Here, APP is linked to Alzheimer disease.